Matches 1 - 50 out of 415 1 2 3 4 5 6 7 8 9 >

AcclaimIP-ad

Match Document Document Title
9040579 Combination therapy using coenzyme Q10 and a caffeic acid-derived ester  
A pharmaceutical composition containing a mitochondrial electron transport chain enhancer (or an antioxidant) and a compound of formula (I) shown in the specification. This pharmaceutical...
9005608 Stabilized solubility-enhanced formulations for oral delivery  
Methods and compositions are described whereby poorly water-soluble beneficial agents such as vitamins and co-factors are formulated into self-emulsifying formulas (SEF) and optionally sorbing the...
8999686 Methods and compositions for producing fatty alcohols  
Methods and compositions, including nucleotide sequences, amino acid sequences, and host cells, for producing fatty alcohols are described.
8946303 Fatigue reducing agent  
To maintain physical fitness and health of middle-aged and older persons living in the threshold of the aging society, the present invention provides a fatigue reducing agent which is highly...
8945540 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof  
Methods and compositions are provided for inhibiting the growth of susceptible microorganisms by contacting the microorganisms, in the presence of a peroxide and chloride or bromide, with...
8946256 Compositions and methods for treatment of vitiligo  
Compositions and methods are disclosed for treating vitiligo and promoting the formation of collagen.
8940295 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes  
The present invention comprises methods and compositions for the reduction of oxalate in humans, and methods for the purification and isolation of recombinant oxalate reducing enzyme proteins. The...
8940861 Variants of ancestral uricases and uses thereof  
The present invention provides uricases and methods of their production and use in reducing the amount of uric acid in a subject. The present invention further provides methods employing a uricase...
8926965 Nucleic acid encoding superoxide dismutase variants and methods of use thereof  
The present disclosure provides variant superoxide dismutase polypeptides, compositions comprising the polypeptides, and nucleic acids comprising nucleotide sequences encoding the polypeptides....
8920793 Biodegradable PAOX polymer particle with cationic property  
The present invention relates to the preparation of poly(amino oxalate) (PAOX) using oxalyl chloride, 1,4-cyclohexanedimethanol, and piperazinediethanol, the preparation of biodegradable polymer...
8900575 Compositions and methods for oxalate reduction  
The present invention comprises methods and compositions for the reduction of oxalate in humans. For example, the invention provides methods and compositions for the delivery of one or more...
8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses  
This invention involves two fields of photoelectron information materials and pharmaceuticals, especially refers to the self-assembly of conducting photoluminescence nanomedicine crystals and thin...
8883137 Compositions comprising selenium-rich yeast and yeast beta-glucan  
A nutritional composition comprising by weight: between 0.05 and 30% selenium-enriched yeast; between 1 and 90% yeast beta-glucan; between 0.5 and 60% Vitamin C; and between 0.5 and 40% Vitamin E....
8883142 Fructosyl peptide oxidase  
A reagent measuring a glycated protein, comprising a protease and a protein of any one of [1] to [4] below: [1] a protein comprising the amino acid sequence represented by SEQ ID NO:1;[2] a...
8852582 Compositions comprising glutathione reductase and oxidized glutathione  
Compositions comprising Glutathione Reductase (GSSG-r) and Oxidized Glutathione (GSSG) or pharmaceutically acceptable salts thereof for pharmaceutical use as antiviral and antibacterial agents and...
8840877 Polysaccharide-protein conjugates reversibly coupled via imine bonds  
Method for preparing an oxidized polysaccharide-protein composition, by (a) oxidizing a polysaccharide with an oxidizing agent to form an oxidized polysaccharide where less than 20% of the...
8840883 Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof  
Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were...
8815234 Treatment of human or animal body surface infection  
A method of treatment of a human or animal body surface infection, particularly a fungal infection, comprises applying an aqueous liquid to the infected body surface, e.g. nail region, followed by...
8802086 Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes  
The present invention relates to specially selected catalase enzymes and their use in reducing hydrogen peroxide in applications, and particularly in aseptic packaging applications.
8790640 Treating inflammation with a binding system  
The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems...
8784813 L-amino acid oxidase with cytotoxic activity from Aplysia punctata  
The present invention relates to a cytotoxic polypeptide which is an L-amino acid oxidase isolated from the ink of the sea hare Aplysia punctata.
8778376 Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating  
A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided.
8778337 Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of alzheimer's disease  
The use of S-adenosylmethionine (SAM) in combination with superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzheimer's disease.
8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection  
Methods and compositions for protecting and treating a muscarinic receptor in an animal or plant from bacterial, fungal, algo or algae infections through administration of at least one...
8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions  
Methods and compositions for protecting muscarinic receptor(s) in a subject from at least one carcinogenic or toxic metal by administration of a pyrophosphate analog. Methods and compositions for...
8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage  
Methods and compositions for enhancing cellular function through protection of a tissue components such receptors, proteins, lipids, nucleic acids, carbohydrates, hormones, vitamins, and...
8741283 Adenosine deaminase anticancer therapy  
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in...
8722040 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites  
The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems...
8709406 Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes  
The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular...
8691206 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide  
In a process of forming a hydrogel from a mixture comprising hydrogen peroxide (H2O2), horseradish peroxidase (HRP), and a polymer comprising a crosslinkable phenol group, the gelation rate in the...
8685433 Absorbable coating for implantable device  
The present invention provides an absorbable coating for an implantable device and the methods of making and using the same.
8679526 Antimicrobial peroxidase compositions  
The present invention discloses a class of compounds which have an enhancing effect on peroxidase based antimicrobial compositions. The invention relates to pharmaceutical compositions for...
8679811 Treatments involving glutaredoxins and similar agents  
The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress...
8673366 Chemotherapeutic and prophylactic pharmaceutical compositions  
The present invention provides pharmaceutical compositions and methods for making the same, which are highly effective against cancer, viruses, amoebae, bacteria (both gram-negative and...
8663630 Promotion of peroxisomal catalase function in cells  
The molecular mechanisms of peroxisome biogenesis have begun to emerge; in contrast, relatively little is known about how the organelle functions as cells age. The present inventors characterized...
8609123 Derivatized poly(ester amide) as a biobeneficial coating  
A derivatized poly(ester amide) (D-PEA) and coatings and medical devices formed therefrom are provided. The coatings and medical devices may optionally include a biobeneficial material and/or a...
8597642 Tablettable formulations of lipophilic health ingredients  
The present invention is directed to a formulation of a lipophilic health ingredient comprising a lipophilic health ingredient, a protective colloid comprising a modified starch and an emulsifier....
8586031 Method of reusing rinse water from disinfecting packages with peracid and catalase  
The present invention relates to specially selected catalase enzymes and their use in reducing hydrogen peroxide in applications, and particularly in aseptic packaging applications.
8586530 Modulation of inhibition of ferrochelatase by N-methyl protoporphyrin  
Provided herein, is a means for development of ferrochelatase variants with improved tolerance towards N-methyl protoporphyrin. Also disclosed are cell assay systems utilizing the variants, as the...
8574570 Bi-stable quantum wire array of self-assembled nanomedicine and the preparation method therefor  
A bi-stable quantum wire array of self-assembled nano-medicine and its process present in the invention. The bi-stable quantum wire array with quantum bit and kondo effect is prepared by...
8557556 Perhydrolase variant providing improved specific activity  
An acetyl xylan esterase variant having perhydrolytic activity is provided for producing peroxycarboxylic acids from carboxylic acid esters and a source of peroxygen. More specifically, a...
8535661 Enzymatically active compositions for suppressing sulfide generation and methods of use thereof  
The present invention provides an enzymatically active composition for suppressing sulfide generation. The composition is free from sulfur dehydrogenase and comprises at least one enzyme having...
8512731 Antimicrobial coatings for medical devices and methods for making and using them  
Embodiments of the invention provide methods for using compositions to inhibit microbial growth on a surface of a medical device having the composition applied thereto, to medical devices having...
8501089 Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes  
The present invention relates to specially selected catalase enzymes and their use in reducing hydrogen peroxide in applications, and particularly in aseptic packaging applications.
8491890 Methods and compositions for inhibiting diseases of the central nervous system  
Methods and compositions for treating central nervous system diseases and disorders are disclosed.
8486678 Pharmaceutical compositions for the treatment of virus infection  
The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that...
8486482 Methods to improve adhesion of polymer coatings over stents  
Methods are disclosed to improved adhesion of polymer coatings over polymer surfaces of stents which include plasma treatment, applying an adhesion promoting layer, surface treatments with...
8486389 Compositions and methods for treating or preventing oxalate-related disease  
The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery...
8465735 Variant form of urate oxidase and use thereof  
The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for...
8460653 Superoxide dismutase variants and methods of use thereof  
The present disclosure provides variant superoxide dismutase polypeptides, compositions comprising the polypeptides, and nucleic acids comprising nucleotide sequences encoding the polypeptides....
Matches 1 - 50 out of 415 1 2 3 4 5 6 7 8 9 >